STERIS Plc (Ireland) (STE) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$220.34

From 52W high−17.38%

Volume477270.00

Market cap$21.64B

P/E (TTM)27.1x

P/S (TTM)3.6x

Div yield0.88%

Key dataOct 19, 2026

Open

$220.34

From 52W high

−17.38%

Volume

477270.00

Market cap

$21.64B

ValuationView details →

P/E (Fwd)

18.9x

EV/EBITDA

14.2x

P/E (TTM)

27.1x

RSI (14)

58.8

MomentumView details →

1D Return

−0.31%

YTD Return

−12.79%

SummaryUpdated Jun 1, 2026

STERIS plc (NYSE:STE) is an Irish-domiciled multinational corporation that provides infection prevention and procedural products and services to healthcare facilities, pharmaceutical manufacturers, and medical device companies worldwide. Founded in 1985 and publicly traded since 1992, the company has grown through strategic acquisitions and organic expansion to become a leading provider of sterilization, disinfection, and surgical equipment solutions. STERIS operates through four main business segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental, serving customers across hospitals, pharmaceutical companies, medical device manufacturers, and dental practices globally.

Ask drillr about STERIS Plc (Ireland) →

ValuationView details →

P/E (Fwd)

18.9x

P/E (TTM)

27.1x

EV/EBITDA

14.2x

EV/Sales

3.8x

P/S (TTM)

3.6x

P/B (TTM)

3.0x

ProfitabilityView details →

Gross Margin

44.43%

Net Margin

13.33%

EBITDA Margin

27.00%

ROE (TTM)

11.17%

ROA (TTM)

7.50%

Asset Turnover

0.56x

GrowthView details →

Revenue YoY

+8.37%

EPS YoY

+25.00%

FCF YoY

+1.85%

Revenue CAGR 3Y

+9.38%

EPS CAGR 3Y

+94.97%

EBITDA YoY

+15.80%

MomentumView details →

1D Return

−0.31%

YTD Return

−12.79%

1Y Return

−8.72%

RSI (14)

58.8

vs 50D SMA

+0.04%

vs 200D SMA

−2.20%

Capital & dividendView details →

Debt/Equity

0.28x

Current Ratio

1.91x

Quick Ratio

1.35x

Div Yield

0.88%

Div Rate

$1.95

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$2.59

EPS Surprise

4.02%

Beats (12Q)

6/12

Next Q EPS Est

$2.81

Avg Surprise (4Q)

2.02%

Rev Surprise

0.34%

Financials snapshotView financials →

Revenue (TTM)

6.04B

Net Income (TTM)

805.10M

Op. CF (TTM)

1.29B

Next earningsNov 4, 2026 →

Latest newsMore news →

STERIS and Purchaser entered into a commitment for up to $2.0 billion in aggregate senior unsecured bridge financing from JPMorgan Chase Bank, N.A. and Goldman Sachs Bank USA.6d ago

STERIS plc, through its wholly owned subsidiary STERIS plc, agreed to acquire all equity interests in STERIS plc for $2.1 billion in cash, with potential earnout consideration of up to $150 million.6d ago

Similar companies

Shanghai MicroPort MedBot (Group) Co., Ltd.02252.HK Hangzhou Diagens Biotechnology Co., Ltd.02526.HK Koninklijke Philips N.V.PHG Zimmer Biomet Holdings, Inc.ZBH DexCom, Inc.DXCM 惠泰医疗688617.SH Find similar companies →

Latest newsMore news →

STERIS and Purchaser entered into a commitment for up to $2.0 billion in aggregate senior unsecured bridge financing from JPMorgan Chase Bank, N.A. and Goldman Sachs Bank USA.6d ago STERIS plc, through its wholly owned subsidiary STERIS plc, agreed to acquire all equity interests in STERIS plc for $2.1 billion in cash, with potential earnout consideration of up to $150 million.6d ago STERIS plc announced that it will buy Xodus Medical, Inc. for $2.1 billion.7d ago